Chugai Pharmaceutical Co., Ltd. 4519.T · Stock Open Chugai Pharmaceutical Co., Ltd. in new tab
Chugai Pharmaceutical Co., Ltd. Analysis (4519.T)
Is Chugai Pharmaceutical Co., Ltd. a good investment? Chugai Pharmaceutical Co., Ltd. (4519.T) is currently trading at 7664.00 JPY. Market analysts have a consensus price target of 9986.67 JPY. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 29.08. This valuation is generally in line with the broader market.
Earnings Schedule: Chugai Pharmaceutical Co., Ltd. is expected to release its next earnings report on July 24, 2026. The market consensus estimate for Forward EPS is 235.91.
For income investors, Chugai Pharmaceutical Co., Ltd. pays a dividend yield of 1.67%. With a payout ratio of 46%, the dividend appears sustainable.
Investor FAQ
Does Chugai Pharmaceutical Co., Ltd. pay a dividend?
Yes, it pays an annual dividend of 132.00 JPY (1.67% yield).
What asset class is Chugai Pharmaceutical Co., Ltd.?
Chugai Pharmaceutical Co., Ltd. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be July 24, 2026. The company currently has a trailing EPS of 263.59.
Company Profile
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept, an immunosuppressant; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi, a spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, an anti VEGF/anti Ang-2 bispecific antibody. The company was formerly known as Chugai Shinyaku Shokai and changed its name to Chugai Pharmaceutical Co., Ltd. in January 1943. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding AG.
| Year | Total Dividends |
|---|---|
| ▸2027 |
182.22 JPY
|
| March 29, 2027 (estimated) | 182.2172 |
| ▸2026 |
277.00 JPY
|
| Dec. 29, 2026 | 65.0000 |
| Aug. 28, 2026 | 65.0000 |
| March 27, 2026 | 147.0000 |
| ▸2025 |
182.00 JPY
|
| Aug. 28, 2025 | 125.0000 |
| March 28, 2025 | 57.0000 |
| ▸2024 |
81.00 JPY
|
| Aug. 29, 2024 | 41.0000 |
| March 29, 2024 | 40.0000 |
| ▸2023 |
78.00 JPY
|
| Aug. 30, 2023 | 40.0000 |
| March 31, 2023 | 38.0000 |
| ▸2022 |
84.00 JPY
|
| Aug. 30, 2022 | 38.0000 |
| March 30, 2022 | 46.0000 |
| ▸2021 |
55.00 JPY
|
| Aug. 30, 2021 | 30.0000 |
| March 24, 2021 | 25.0000 |
| ▸2020 |
117.00 JPY
|
| Aug. 28, 2020 | 25.0000 |
| March 31, 2020 | 91.9999 |
| ▸2019 |
103.00 JPY
|
| Aug. 30, 2019 | 47.9999 |
| March 29, 2019 | 54.9999 |
| ▸2018 |
64.00 JPY
|
| Aug. 31, 2018 | 31.0000 |
| March 23, 2018 | 33.0000 |
| ▸2017 |
29.00 JPY
|
| Sept. 1, 2017 | 29.0000 |
| ▸2016 |
52.00 JPY
|
| Dec. 28, 2016 | 26.0000 |
| June 28, 2016 | 26.0000 |
| ▸2015 |
58.00 JPY
|
| Dec. 28, 2015 | 32.0000 |
| June 26, 2015 | 26.0000 |
| ▸2014 |
48.00 JPY
|
| Dec. 26, 2014 | 26.0000 |
| June 26, 2014 | 22.0000 |
| ▸2013 |
45.00 JPY
|
| Dec. 26, 2013 | 23.0000 |
| June 26, 2013 | 22.0000 |
| ▸2012 |
40.00 JPY
|
| Dec. 26, 2012 | 20.0000 |
| June 27, 2012 | 20.0000 |
| ▸2011 |
40.00 JPY
|
| Dec. 28, 2011 | 20.0000 |
| June 28, 2011 | 20.0000 |
| ▸2010 |
40.00 JPY
|
| Dec. 28, 2010 | 23.0000 |
| June 28, 2010 | 17.0000 |
| ▸2009 |
40.00 JPY
|
| Dec. 28, 2009 | 23.0000 |
| June 25, 2009 | 17.0000 |
| ▸2008 |
34.00 JPY
|
| Dec. 25, 2008 | 19.0000 |
| June 25, 2008 | 15.0000 |
| ▸2007 |
30.00 JPY
|
| Dec. 25, 2007 | 15.0000 |
| June 26, 2007 | 15.0000 |
| ▸2006 |
30.00 JPY
|
| Dec. 26, 2006 | 18.0000 |
| June 27, 2006 | 12.0000 |
| ▸2005 |
22.00 JPY
|
| Dec. 27, 2005 | 10.0000 |
| June 27, 2005 | 12.0000 |
| ▸2004 |
18.00 JPY
|
| Dec. 27, 2004 | 9.0000 |
| June 25, 2004 | 9.0000 |
| ▸2003 |
21.00 JPY
|
| Dec. 25, 2003 | 13.0000 |
| March 26, 2003 | 8.0000 |
| ▸2002 |
16.00 JPY
|
| Sept. 25, 2002 | 8.0000 |
| March 26, 2002 | 8.0000 |
| ▸2001 |
17.50 JPY
|
| Sept. 25, 2001 | 8.0000 |
| March 27, 2001 | 9.5000 |
| ▸2000 |
13.75 JPY
|
| Sept. 26, 2000 | 6.5000 |
| March 28, 2000 | 7.2500 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | Dec 29, 2026 | Upcoming | 65.0 JPY |
| Chugai Pharmaceutical Co., Ltd. | Aug 28, 2026 | Upcoming | 65.0 JPY |
| Chugai Pharmaceutical Co., Ltd. | Mar 27, 2026 | Paid | 147.0 JPY |
| Chugai Pharmaceutical Co., Ltd. | Aug 28, 2025 | Paid | 125.0 JPY |
| Split Date | Split Ratio to 1 |
|---|---|
| June 29, 2020 | 3.000000 |
Community Discussion